A Pseudomonas aeruginosa endolytic muramidase targets cell-wall peptidoglycan in bacterial competition

Tietao Wang, Lin Zhang, Mijoon Lee, W. C. Yan, Qian Liu, Chenchen Wang, Rhona Feltzer, Dušan Hesek, Shahriar Mobashery, Liang Zhang, Haihua LiangJournal of Biological Chemistry 2025 · DOI

TL;DR

Pseudomonas aeruginosa, a common opportunistic pathogen, employs a newly identified toxin, PseM, to break down the cell walls of competing bacteria. This mechanism, delivered via the type VI secretion system (T6SS), grants P. aeruginosa a significant competitive edge in mixed microbial communities.

What Problem Does This Paper Address?

Microbial communities are battlegrounds where bacteria constantly vie for resources and space. Pseudomonas aeruginosa is a notorious opportunist, often found in chronic infections within these complex environments. To survive and thrive, it deploys a diverse arsenal of weapons, including the sophisticated type VI secretion system (T6SS), which can deliver toxic effectors to neighboring cells. While many T6SS effectors are known, the full spectrum of these antibacterial weapons and their precise mechanisms remain an active area of research. This paper aims to identify and characterize a novel T6SS-delivered antibacterial toxin from P. aeruginosa and elucidate its role in interbacterial competition.

Methods

The researchers employed a multi-pronged approach:

  • Genetic manipulation: They created knockout mutants and expression constructs to study the role of specific genes (like pseM and its immunity partner PA0990) and protein domains (like the signal peptide).
  • Bacterial growth assays: Standard plate-based growth assays and time-lapse microscopy were used to observe the effects of PseM on E. coli and other bacteria.
  • Subcellular fractionation and Western blotting: These techniques were used to determine where PseM is located within the cell and whether it is secreted.
  • Biochemical assays: The EnzChek Lysozyme Assay Kit and synthetic peptidoglycan substrates were used to directly measure PseM's enzymatic activity.
  • Structural biology: X-ray crystallography was used to determine the 3D structure of PseM, revealing its homodimeric nature and active site.
  • Computational modeling: Macromolecular docking simulations were employed to predict how PseM interacts with its substrate.
  • Co-immunoprecipitation (Co-IP) assays: These were used to confirm the physical interaction between PseM and its immunity protein PA0990.
  • Phylogenetic analysis: This was used to understand the evolutionary distribution of PseM homologs across different bacterial species.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • A novel T6SS effector: PseM is identified as a new T6SS-secreted toxin from P. aeruginosa. This expands our understanding of the bacterial "arms race" mediated by T6SS.
  • Targeted cell wall destruction: PseM acts as an endolytic muramidase, specifically cleaving the peptidoglycan backbone of competitor bacteria. This is a direct assault on a fundamental bacterial structure.
  • Signal peptide is crucial for toxicity: The N-terminal signal peptide of PseM is essential for its toxic activity, suggesting it plays a key role in targeting or delivery.
  • Periplasmic localization: PseM is found in the periplasmic space, the region between the inner and outer bacterial membranes. This localization is critical for its function.
  • Immunity protein identified: PA0990 acts as an immunity protein, directly binding to PseM to prevent self-toxicity. This highlights the co-evolution of toxins and their cognate immunity factors.
  • Structural basis for activity: The crystal structure reveals PseM is a homodimer, with the active site formed by contributions from both monomers. This dimerization is key to its function.
  • Contribution to competitive fitness: PseM significantly enhances P. aeruginosa's ability to outcompete other bacteria, particularly Gram-negative species.

Key Results

  • PseM expression and secretion are negatively regulated by the RetS-Rsm signaling pathway in P. aeruginosa.
  • PseM secretion is dependent on the T6SS, with complete abolition observed in a triple clpV deletion mutant.
  • PseM induces cell lysis in E. coli and increases cell membrane permeability.
  • PseM exhibits peptidoglycan-degrading activity in vitro, acting as an endolytic muramidase with some exolytic activity.
  • The crystal structure of PseM reveals a unique homodimeric fold, with a zinc ion likely involved in catalysis.
  • Macromolecular docking suggests PseM binds to a peptidoglycan substrate in a crevice near the dimer interface.
  • Mutagenesis studies identified key residues (Tyr36, Arg90, Glu120, Arg128) essential for PseM's toxic activity and peptidoglycan hydrolytic function.
  • Interspecies competition assays showed that P. aeruginosa lacking PseM is significantly outcompeted by E. coli and Yersinia pseudotuberculosis.
  • PseM homologs are widely distributed across Pseudomonas species, suggesting a conserved role in bacterial competition.

Limitations and Future Work

  • Mechanism of T6SS secretion: While PseM is T6SS-dependent and has a signal peptide, the precise mechanism of its secretion via T6SS, especially with the signal peptide, is still unclear and warrants further investigation. The authors suggest a novel secretion pattern where the signal peptide-bearing effector might be loaded onto the T6SS apparatus in the periplasm.
  • PA0990's precise function: While PA0990 is identified as an immunity protein and predicted to have ADP-ribosyl hydrolase activity, its exact role in counteracting PseM's toxicity needs further elucidation.
  • Substrate specificity: While PseM shows preference for substrates with stem peptides and longer sugar backbones, a more comprehensive understanding of its precise substrate specificity across various bacterial peptidoglycans would be beneficial.
  • In vivo relevance: While the study demonstrates PseM's role in in vitro competition, further studies are needed to fully understand its contribution to P. aeruginosa's success in complex in vivo environments like chronic infections.
  • Evolutionary context: The phylogenetic analysis shows widespread distribution of PseM homologs, but a deeper dive into the evolutionary pressures driving the diversification and acquisition of such toxins could be explored.

Summary updated

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that frequently resides in multispecies communities. During chronic infections, P. aeruginosa employs a diverse arsenal of antibacterial weapons to compete with other bacteria for resources and space. Using genetic and biochemical approaches, we identified a type VI secretion system-dependent antibacterial effector-immunity pair, PseM (P. aeruginosa secreted endolytic muramidase) and PA0990 in P. aeruginosa. Our findings demonstrate that PseM functions as an endolytic muramidase, targeting prey bacteria by hydrolytically cleaving cell-wall peptidoglycan, whereas its immunity partner PA0990 provides self-protection. The X-ray crystal structure of PseM reveals a homodimeric configuration, with its active site formed by segments from both monomers. Through structural analysis and macromolecular docking simulations, we further elucidate the substrate-binding residues critical for the activity of PseM. Importantly, we show that PseM contributes to P. aeruginosa growth among bacterial competition. Together, these results uncover a novel antibacterial mechanism mediated by PseM, highlighting the dynamic nature of interspecies and intraspecies competition within bacterial populations.
BibTeX
@article{wang2025pseudomonas,
  author = {Tietao Wang and Lin Zhang and Mijoon Lee and W. C. Yan and Qian Liu and Chenchen Wang and Rhona Feltzer and Dušan Hesek and Shahriar Mobashery and Liang Zhang and Haihua Liang},
  title = {{A Pseudomonas aeruginosa endolytic muramidase targets cell-wall peptidoglycan in bacterial competition}},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110642},
}
Figure